Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

HKG:2607 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39,140	35,744	30,518	27,401	22,390	22,354
Trading Asset Securities	8,405	8,633	10,152	9,614	-	-
Cash & Short-Term Investments	47,545	44,377	40,670	37,015	22,390	22,354
Cash Growth	6.08%	9.12%	9.87%	65.32%	0.16%	22.83%
Accounts Receivable	89,131	82,217	77,163	70,187	61,006	55,522
Other Receivables	2,123	2,237	2,373	1,957	1,786	1,343
Receivables	91,253	84,454	79,536	72,144	62,791	56,865
Inventory	40,899	38,944	36,623	34,460	27,104	24,088
Other Current Assets	4,759	4,048	5,605	5,894	4,209	4,255
Total Current Assets	184,457	171,823	162,434	149,513	116,494	107,563
Property, Plant & Equipment	19,237	19,175	18,006	16,550	15,793	14,626
Long-Term Investments	8,648	9,835	10,603	11,477	10,836	7,663
Goodwill	12,836	11,146	11,393	11,336	11,239	11,342
Other Intangible Assets	9,164	5,617	6,051	6,263	6,049	5,195
Long-Term Deferred Tax Assets	1,719	1,628	1,717	1,535	1,368	1,359
Long-Term Deferred Charges	778.81	749.89	785.22	342.61	259.23	639.15
Other Long-Term Assets	1,227	1,236	983.3	1,119	1,397	797.64
Total Assets	238,067	221,209	211,973	198,135	163,436	149,186
Accounts Payable	63,012	59,483	54,632	51,566	41,995	37,792
Accrued Expenses	11,684	10,637	10,638	9,574	7,985	6,816
Short-Term Debt	51,649	44,096	41,612	33,811	31,592	25,158
Current Portion of Long-Term Debt	2,864	191.8	2,366	2,649	33.44	8,311
Current Portion of Leases	558.71	649.07	596.67	580.68	545.04	574.57
Current Income Taxes Payable	721.29	835.87	809.8	781.36	721.16	682.45
Current Unearned Revenue	1,213	1,562	1,971	2,243	1,311	1,311
Other Current Liabilities	8,429	8,583	9,747	9,487	7,642	7,488
Total Current Liabilities	140,131	126,038	122,372	110,691	91,824	88,133
Long-Term Debt	4,698	8,331	5,786	6,260	7,158	1,184
Long-Term Leases	1,409	1,396	1,550	1,302	1,434	1,501
Long-Term Unearned Revenue	603.63	550.99	633.48	534.58	2,349	2,224
Long-Term Deferred Tax Liabilities	2,024	816.45	1,016	1,049	998.77	832.38
Other Long-Term Liabilities	286.2	294.44	250.14	257.26	566.09	570.39
Total Liabilities	149,209	137,467	131,646	120,132	104,369	94,445
Common Stock	3,708	3,708	3,703	3,698	2,842	2,842
Additional Paid-In Capital	29,696	29,648	29,188	29,098	16,071	15,898
Retained Earnings	42,222	38,854	36,129	34,639	30,591	26,880
Comprehensive Income & Other	-530.12	-534.28	-496.09	-371.32	-144.39	-265.41
Total Common Equity	75,096	71,676	68,524	67,063	49,359	45,355
Minority Interest	13,762	12,067	11,802	10,939	9,707	9,386
Shareholders' Equity	88,858	83,742	80,326	78,002	59,066	54,741
Total Liabilities & Equity	238,067	221,209	211,973	198,135	163,436	149,186
Total Debt	61,180	54,664	51,911	44,602	40,762	36,728
Net Cash (Debt)	-13,635	-10,287	-11,241	-7,587	-18,372	-14,374
Net Cash Per Share	-3.68	-2.78	-3.04	-2.18	-6.46	-5.06
Filing Date Shares Outstanding	3,708	3,708	3,703	3,698	2,842	2,842
Total Common Shares Outstanding	3,708	3,708	3,703	3,698	2,842	2,842
Working Capital	44,326	45,785	40,062	38,822	24,670	19,430
Book Value Per Share	20.25	19.33	18.50	18.14	17.37	15.96
Tangible Book Value	53,095	54,913	51,080	49,464	32,071	28,817
Tangible Book Value Per Share	14.32	14.81	13.79	13.38	11.28	10.14
Buildings	13,803	13,455	10,959	10,941	9,698	9,351
Machinery	11,569	11,302	9,982	9,054	8,203	7,743
Construction In Progress	2,382	2,149	3,570	2,777	2,914	1,737

Source: S&P Global Market Intelligence. Standard template. Financial Sources.